Lipid metabolic pathways as lung cancer therapeutic targets: A computational study

TE StinchcombeMA SocinskiCurrent treatments for advanced stage non-small cell lung cancerProc Am Thorac Soc6233241200910.1513/pats.200809-110LC19349493

T MitsudomiY YatabeMutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancerCancer Sci9818171824200710.1111/j.1349-7006.2007.00607.x

J BeanC BrennanJY ShihG RielyA VialeL WangMET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibProc Natl Acad Sci USA1042093220937200710.1073/pnas.071037010418093943

S YanoW WangQ LiK MatsumotoH SakuramaT NakamuraHepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutationsCancer Res6894799487200810.1158/0008-5472.CAN-08-164319010923

WR FarwellRE ScrantonEV LawlerRA LewMT BrophyLD FioreThe association between statins and cancer incidence in a veterans populationJ Natl Cancer Inst100134139200810.1093/jnci/djm28618182618

V KhuranaHR BejjankiG CalditoMW OwensStatins reduce the risk of lung cancer in humans: a large case-control study of us veteransChest13112821288200710.1378/chest.06-093117494779

ML TaylorBJ WellsMJ SmolakStatins and cancer: a meta-analysis of case-control studiesEur J Cancer Prev17259268200810.1097/CEJ.0b013e3282b721fe18414198

J HaukkaR SankilaT KlaukkaJ LonnqvistL NiskanenA TanskanenIncidence of cancer and statin usage-record linkage studyInt J Cancer126279284201010.1002/ijc.2453619739258

AJ ManthaKE McFeeN NiknejadG GossIA LorimerJ DimitroulakosEpidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cellsJ Cancer Res Clin Oncol129631641200310.1007/s00432-003-0490-2

AJ ManthaJE HansonG GossAE LagardeIA LorimerJ DimitroulakosTargeting the mevalonate pathway inhibits the function of the epidermal growth factor receptorClin Cancer Res1123982407200510.1158/1078-0432.CCR-04-195115788691

T KusamaM MukaiT IwasakiM TatsutaY MatsumotoH AkedoInhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitorsCancer Res61488548912001

IH ParkJY KimJI JungJY HanLovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutationsInvest New Drugs28791799201010.1007/s10637-009-9319-419760159

I BuhaescuH IzzedineMevalonate pathway: a review of clinical and therapeutical implicationsClin Biochem40575584200710.1016/j.clinbiochem.2007.03.01617467679

LJ PikeL CaseyCholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and traffickingBiochemistry411031510322200210.1021/bi025943i12162747

T RingerikeFD BlystadFO LevyIH MadshusE StangCholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolaeJ Cell Sci11513311340200211884532

G ParmigianiE Garrett-MayerR AnbazhaganE GabrielsonA cross-study comparison of gene expression studies for the molecular classification of lung cancerClin Cancer Res1029222927200410.1158/1078-0432.CCR-03-049015131026

DA WigleI JurisicaN RadulovichM PintilieJ RossantN LiuMolecular profiling of non-small cell lung cancer and correlation with disease-free survivalCancer Res6230053008200212036904

DR RhodesJ YuK ShankerN DeshpandeR VaramballyD GhoshLarge-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progressionProc Natl Acad Sci USA10193099314200410.1073/pnas.040199410115184677

MT LandiT DrachevaM RotunnoJD FigueroaH LiuA DasguptaGene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survivalPLoS One3e1651200810.1371/journal.pone.000165118297132

T BarrettDB TroupSE WilhiteP LedouxD RudnevC EvangelistaNCBI GEO: archive for high-throughput functional genomic dataNucleic Acids Res37D885D890200910.1093/nar/gkn76418940857

G DennisBT ShermanDA HosackJ YangW GaoHC LaneDAVID: Database for annotation, visualization, and integrated discoveryGenome Biol4P3200310.1186/gb-2003-4-5-p312734009

DW HuangBT ShermanRA LempickiSystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc44457200919131956

SY RheeV WoodK DolinskiS DraghiciUse and misuse of the gene ontology annotationsNat Rev Genet9509515200810.1038/nrg236318475267

Y BenjaminiD DraiG ElmerN KafkafiI GolaniControlling the false discovery rate in behavior genetics researchBehav Brain Res125279284200110.1016/S0166-4328(01)00297-211682119

SI BergerJM PosnerA Ma’ayanGenes2networks: connecting lists of gene symbols using mammalian protein interactions databasesBMC Bioinformatics8372200710.1186/1471-2105-8-37217916244

PM WatsonSW MillerM FraigDJ ColeDK WatsonAM BoylanCaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypesAm J Respir Cell Mol Biol38671678200810.1165/rcmb.2007-0205OC18218995

X CasabiellJL ZugazaCM PomboA PandiellaFF CasanuevaOleic acid blocks epidermal growth factor-activated early intracellular signals without altering the ensuing mitogenic responseExp Cell Res205365373199310.1006/excr.1993.1099

KE McKenzieGK BandyopadhyayW ImagawaK SunS NandiOmega-3 and omega-6 fatty acids and PGE2 stimulate the growth of normal but not tumor mouse mammary epithelial cells: evidence for alterations in the signaling pathways in tumor cellsProstaglandins Leukot Essent Fatty Acids51437443199410.1016/0952-3278(94)90062-0

S MollerupA HaugenDifferential effect of polyunsaturated fatty acids on cell proliferation during human epithelial in vitro carcinogenesis: involvement of epidermal growth factor receptor tyrosine kinaseBr J Cancer74613618199610.1038/bjc.1996.410

F BennisG FavreFL GaillardG SoulaImportance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549Int J Cancer55640645199310.1002/ijc.29105504218406993

J FukuchiC SongAL KoS LiaoTranscriptional regulation of farnesyl pyrophosphate synthase by liver X receptorsSteroids68685691200310.1016/S0039-128X(03)00100-412957674

BM FormanB RuanJ ChenGJ SchroepferRM EvansThe orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolismProc Natl Acad Sci USA941058810593199710.1073/pnas.94.20.105889380679

T TeranoT ShiinaY NoguchiT TanakaI TatsunoY SaitoGeranylgeranylpyrophosphate plays a key role for the G1 to S transition in vascular smooth muscle cellsJ Atheroscler Thromb516199810.5551/jat1994.5.110077451

HR AsharL JamesK GrayD CarrS BlackL ArmstrongFarnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubulesJ Biol Chem2753045130457200010.1074/jbc.M00346920010852915

A ShammaY TakegamiT MikiS KitajimaM NodaT ObaraRb regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylationCancer Cell15255269200910.1016/j.ccr.2009.03.00119345325

S KasayamaM KogaH KouharaS SumitaniK WadaT KishimotoUnsaturated fatty acids are required for continuous proliferation of transformed androgen-dependent cells by fibroblast growth factor family proteinsCancer Res54644164451994

CB RenardB AskariLA SuzukiF KramerKE BornfeldtOleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cellsDiabetologia4616761687200310.1007/s00125-003-1247-914595542

MN GraberA AlfonsoDL GillRecovery of Ca²⁺ pools and growth in Ca²⁺ pool-depleted cells is mediated by specific epoxyeicosatrienoic acids derived from arachidonic acidJ Biol Chem272295462955319979368016

MR YunJY LeeHS ParkHJ HeoJY ParkSS BaeOleic acid enhances vascular smooth muscle cell proliferation via phosphatidylinositol 3-kinase/AKT signaling pathwayPharmacol Res5497102200610.1016/j.phrs.2006.03.00116621593

E NikiLipid peroxidation: physiological levels and dual biological effectsFree Radic Biol Med47469484200910.1016/j.freeradbiomed.2009.05.03219500666

A TrombettaM MaggioraG MartinassoP CotogniRA CanutoG MuzioArachidonic and docosahexaenoic acids reduce the growth of A549 human lung-tumor cells increasing lipid peroxidation and PPARsChem Biol Interact165239250200710.1016/j.cbi.2006.12.01417275799

L MaehleE LystadE EilertsenE EinarsdottrAT HstmarkA HaugenGrowth of human lung adenocarcinoma in nude mice is influenced by various types of dietary fat and vitamin EAnticancer Res1916491655199910470096

K MatuokaKY ChenTranscriptional regulation of cellular ageing by the CCAAT box-binding factor CBF/NF-YAgeing Res Rev1639651200210.1016/S1568-1637(02)00026-012362892

SD ClarkePolyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndromeJ Nutr13111291132200111285313

BD ReedAE CharosAM SzekelySM WeissmanM SnyderGenome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genesPLoS Genet4e1000133200810.1371/journal.pgen.100013318654640

Q HuSN MaityStable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genesJ Biol Chem27544354444200010.1074/jbc.275.6.4435

AL ChabesS BjrklundL ThelanderS phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating regionJ Biol Chem2791079610807200410.1074/jbc.M312482200

H KoesslerJ KahleC BodeD DoeneckeW AlbigHuman replication-dependent histone H3 genes are activated by a tandemly arranged pair of two CCAAT boxesBiochem J384317326200410.1042/BJ2004050215320874

KS KatulaKL WrightH PaulDR SurmanFJ NuckollsJW SmithCyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elementsCell Growth Differ881182019979218875

S JinF FanW FanH ZhaoT TongP BlanckTranscription factors OCT-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damageOncogene2026832690200110.1038/sj.onc.120439011420680

I ManniG MazzaroA GurtnerR MantovaniU HaugwitzK KrauseNF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrestJ Biol Chem27655705576200110.1074/jbc.M00605220011096075

HT KimJE LeeES ShinYK YooJH ChoMH YunEffect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapyJ Clin Oncol2659725979200810.1200/JCO.2008.16.649619018088

I BoukovinasC PapadakiP MendezM TaronD MavroudisA KoutsopoulosTumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patientsPLoS One3e3695200810.1371/journal.pone.000369519002265

M VolmR KoomgiRelevance of proliferative and proapoptotic factors in non-small-cell lung cancer for patient survivalBr J Cancer8217471754200010817513

T OyamaT OsakiN NoseY IchikiM InoueH ImotoEvaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinomaAnticancer Res20505510200010769714

Q ZhouY SuM BaiEffect of antisense RNA targeting polo-like kinase 1 on cell growth in A549 lung cancer cellsJ Huazhong Univ Sci Technolog Med Sci282226200810.1007/s11596-008-0106-918278450

B Spnkuch-SchmittG WolfC SolbachS LoiblR KnechtM StegmllerDownregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cellsOncogene2131623171200210.1038/sj.onc.120541212082631

DF TanJA HubermanA HylandGM LoewenJS BrooksAF BeckMCM2-a promising marker for premalignant lesions of the lung: a cohort studyBMC Cancer16200110.1186/1471-2407-1-611472637

D ThompsonS SealM SchutteL McGuffogR BarfootA RenwickA multicenter study of cancer incidence in CHEK2 1100delC mutation carriersCancer Epidemiol Biomarkers Prev1525422545200610.1158/1055-9965.EPI-06-068717164383

C CybulskiB MasojcD OszutowskaE JaworowskaT GrodzkiP WaloszczykConstitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancersCarcinogenesis29762765200810.1093/carcin/bgn04418281249

M VolmR KoomgiW RittgenClinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinomaInt J Cancer79294299199810.1002/(SICI)1097-0215(19980619)79:3%3C294::AID-IJC15%3E3.0.CO;2-89645354

S FujiokaK ShomoriK NishiharaK YamagaK NosakaK ArakiExpression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): prognostic implicationLung Cancer65223229200910.1016/j.lungcan.2008.11.00719144445

HL Neville-WebbeCA EvansRE ColemanI HolenMechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitroTumour Biol2792103200610.1159/000092489

WT GunningPM KramerRA LubetVE SteeleDW EndW WoutersMA PereiraChemoprevention of benzo(a)pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R115777Clin Cancer Res919271930200312738751

C MorganPD LewisRM JonesG BertelliGA ThomasRC LeonardThe in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancerActa Oncol46669677200710.1080/0284186060099644717562444

SF Doisneau-SixouP CestacJC FayeG FavreRL SutherlandAdditive effects of tamoxifen and the farnesyl transferase inhibitor FTI-277 on inhibition of MCM-7 breast cancer cell-cycle progressionInt J Cancer106789798200310.1002/ijc.1126312866041

D BruemmerF YinJ LiuT KiyonoE FleckAV HerleAtorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cellsEur J Pharmacol4621523200310.1016/S0014-2999(03)01317-712591091

W FanS JinT TongH ZhaoF FanMJ AntinoreBRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifsJ Biol Chem27780618067200210.1074/jbc.M11022520011777930

HD ChaeJ YunYJ BangDY ShinCdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitionsOncogene2340844088200410.1038/sj.onc.120748215064732

V SalsiG CarettiM WasnerW ReinhardU HaugwitzK EngelandInteractions between P300 and multiple NF-Y trimers govern cyclin b2 promoter functionJ Biol Chem27866426650200310.1074/jbc.M21006520012482752

H GoodarziO ElementoS TavazoieRevealing global regulatory perturbations across human cancersMol Cell36900911200910.1016/j.molcel.2009.11.01620005852

K YamanakaS MizuaraiT EguchiH ItadaniH HiraiH KotaniExpression levels of NF-Y target genes changed by CDKN1B correlate with clinical prognosis in multiple cancersGenomics94219227200910.1016/j.ygeno.2009.06.00319559782